Home / Health / NHS Taps Covid Pass Firm for Cancer Screening Speed-Up
NHS Taps Covid Pass Firm for Cancer Screening Speed-Up
3 Sep
Summary
- Netcompany secured a £215 million contract with the NHS.
- The deal aims to accelerate cancer screening processes.
- Digital platforms will replace outdated legacy systems.
Netcompany Group A/S, the developer behind the UK's Covid Pass application during the pandemic, has secured a substantial five-year contract with the National Health Service. This significant deal is worth more than £215 million ($290 million) and is specifically aimed at accelerating cancer screening processes within the UK's healthcare system.
The Danish company's mandate includes the comprehensive replacement of existing legacy systems. Netcompany will introduce advanced digital platforms designed to cover all aspects of cancer screening, thereby modernizing critical healthcare infrastructure and improving patient outcomes through enhanced efficiency and speed.
